Recherche en direct
TopFind récupère les correspondances les plus récentes pour votre recherche.
Nous avons examiné 576 résultats en direct pour liquidhallmark liquid biopsy et retenu les 3 options qui semblent les plus utiles à comparer en premier.
Les thèmes les plus forts dans cette sélection sont Liquid Biopsy et Oncology.
Source: Lucence
Description
An ultra-sensitive liquid biopsy blood test that detects tumor-derived DNA and RNA. It is used to identify actionable genomic alterations for personalized cancer therapy selection and treatment monitoring without a tissue biopsy.
Idéal pour
Liquid biopsy seekers, Personalized therapy, Non Invasive profiling et Genomic monitoring
Évaluation
Source: Lucence
Description
A sophisticated cancer profiling test that uses liquid biopsy to detect DNA and RNA signals from a simple blood draw. The analysis is supported by proprietary AI algorithms to provide actionable genomic insights for personalized cancer treatment.
Idéal pour
Oncology patients, Cancer clinics, Personalized medicine et Precision diagnostics
Évaluation
Source: Guardant Health AMEA
Description
A comprehensive liquid biopsy assay designed to profile genomic alterations in advanced cancer patients using a simple blood draw.
Idéal pour
Advanced cancer patients, Non Invasive profiling, Precision oncology et Liquid biopsy
Évaluation
| Comparer | LiquidHALLMARK® | LiquidHALLMARK Liquid Biopsy | Guardant360 Liquid Biopsy Profiling |
|---|---|---|---|
| Source | Lucence | Lucence | Guardant Health AMEA |
| Description | An ultra-sensitive liquid biopsy blood test that detects tumor-derived DNA and RNA. It is used to identify actionable genomic alterations for personalized cancer therapy selection and treatment monitoring without a tissue biopsy. | A sophisticated cancer profiling test that uses liquid biopsy to detect DNA and RNA signals from a simple blood draw. The analysis is supported by proprietary AI algorithms to provide actionable genomic insights for personalized cancer treatment. | A comprehensive liquid biopsy assay designed to profile genomic alterations in advanced cancer patients using a simple blood draw. |
| Idéal pour | Liquid biopsy seekers, Personalized therapy, Non Invasive profiling et Genomic monitoring | Oncology patients, Cancer clinics, Personalized medicine et Precision diagnostics | Advanced cancer patients, Non Invasive profiling, Precision oncology et Liquid biopsy |
| Action | |||
| Évaluation |
Si vous voulez commencer par l'option la plus équilibrée, je vous recommande :
"LiquidHALLMARK® de Lucence."
Je l'ai choisi parce que Excellent for patients requiring non-invasive genomic profiling to guide targeted cancer treatments.